Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Re: clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.

Laguna MP.

J Urol. 2013 Aug;190(2):493-4. doi: 10.1016/j.juro.2013.04.068. Epub 2013 Apr 30. No abstract available.

PMID:
23845327
2.

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.

Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ.

Eur Urol. 2013 May;63(5):848-54. doi: 10.1016/j.eururo.2012.09.005. Epub 2012 Sep 27.

3.

The changing face of renal cell carcinoma: the impact of systematic genetic sequencing on our understanding of this tumor's biology.

Catto JW, Shariat SF.

Eur Urol. 2013 May;63(5):855-7; discussion 857-8. doi: 10.1016/j.eururo.2012.09.049. Epub 2012 Sep 26. No abstract available.

PMID:
23026395
4.

The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM.

Am J Pathol. 2013 Apr;182(4):1163-70. doi: 10.1016/j.ajpath.2013.01.007. Epub 2013 Feb 12.

5.

[Connexin32 as a tumor suppressor gene in renal cell carcinoma].

Fujimoto E, Yano T, Ueno K.

Nihon Yakurigaku Zasshi. 2007 Feb;129(2):105-9. Review. Japanese. No abstract available.

PMID:
17299236
6.

[Frequent somatic mutations of the von Hippel-Lindau (VHL) tumor suppressor gene and its meaning in sporadic human renal clear cell carcinoma].

Gong K, Zhang N, Guo HF, Zhang ZW, Xin DQ, Na YQ.

Beijing Da Xue Xue Bao. 2004 Apr;36(2):169-72. Chinese.

7.

Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.

Oike T, Ogiwara H, Nakano T, Yokota J, Kohno T.

Jpn J Clin Oncol. 2013 Sep;43(9):849-55. doi: 10.1093/jjco/hyt101. Epub 2013 Jul 30.

8.

A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma.

Sanjmyatav J, Steiner T, Wunderlich H, Diegmann J, Gajda M, Junker K.

J Urol. 2011 Jul;186(1):289-94. doi: 10.1016/j.juro.2011.03.033. Epub 2011 May 20.

PMID:
21600596
9.

Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, et al.

Cancer Res. 1994 Jun 1;54(11):2852-5.

10.

Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.

Hamano K, Esumi M, Igarashi H, Chino K, Mochida J, ISHIDA And H, Okada K.

J Urol. 2002 Feb;167(2 Pt 1):713-7.

PMID:
11792959
11.

VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.

Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker HJ.

Cancer Res. 2000 Apr 1;60(7):1942-8.

12.
13.

[VHL, angiogenesis and renal carcinoma: the puzzle is complete].

Richard S.

Ann Pathol. 2000 Mar;20(2):107-9. French. No abstract available.

PMID:
10740003
14.
15.
16.

von Hippel-Lindau gene mutations in human and rodent renal tumors--association with clear cell phenotype.

Gnarra JR.

J Natl Cancer Inst. 1998 Nov 18;90(22):1685-7. No abstract available.

17.

Re: clonal origin of multifocal renal cell carcinoma as determined by microsatellite analysis.

Kovacs G.

J Urol. 2003 Oct;170(4 Pt 1):1325-6; author reply 1326. No abstract available.

PMID:
14501758
18.

Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.

Hum Genet. 2003 Feb;112(2):178-85. Epub 2002 Nov 13.

PMID:
12522559
19.

The genetic basis of cancer of the kidney.

Linehan WM, Walther MM, Zbar B.

J Urol. 2003 Dec;170(6 Pt 1):2163-72. Review.

PMID:
14634372
20.

[Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].

Shuin T, Kamata M, Ashida S.

Gan To Kagaku Ryoho. 2002 Oct;29(10):1719-25. Japanese.

PMID:
12402420
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk